Scientists from the National Institutes of Health (NIH) have discovered how catheter-related bacterial infection develops and disseminates to become a potentially life-threatening condition. The study, which included research on Staphylococcus epidermidis in mice implanted with catheters, could have important implications for understanding many types of bacterial biofilm infections, including those caused by methicillin-resistant S. aureus (MRSA).
Biofilms are clusters of microbes that almost always are found with healthcare-associated infections (HAIs) involving medical devices such as catheters, pacemakers and prosthetics. Most often biofilms that develop on such devices consist of Staph bacteria. Because biofilms inherently resist antibiotics and immune defenses, treating patients with biofilm-associated infections can be difficult and expensive. An estimated two million HAIs, most of which are associated with biofilms, occur in the United States annually, accounting for about 100,000 deaths.
Although biofilm-related infections result in significant numbers of deaths, scientists still have a limited understanding of how biofilms develop at a molecular level. But now scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) have identified a specific S. epidermidis protein, called phenol-soluble modulin beta (PSM-beta), that biofilms use for multiple purposes: to grow, to detach from an implanted medical device, and to disseminate infection. Antibodies against PSM-beta slowed bacterial spread within the study mice, suggesting that interfering with biofilm development could provide a way to stop the spread of biofilm-associated infection.
Similar proteins also are found in S. aureus, and the research group now plans to study their role in biofilms of MRSA and other bacteria.
Reference: Wang R, et al. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. The Journal of Clinical Investigation 121(1): DOI: 10.1172/JCI42520 (2011).
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Environmental Hygiene: Air Pressure and Ventilation: Negative vs Positive Pressure
December 10th 2024Learn more about how effective air pressure regulation in health care facilities is crucial for controlling airborne pathogens like tuberculosis and COVID-19, ensuring a safer environment for all patients and staff.
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
Why Clinical Expertise Is the Cornerstone to Your Most Profitable Business Line
November 14th 2024Perioperative nurses bring vital skills in patient safety, infection control, and quality improvement. They enhance surgical outcomes and support health care systems during complex, high-risk procedures.